Merck Stock Quote Today

MRK -  USA Stock  

USD 72.04  0.29  0.40%

Merck is trading at 72.04 as of the 27th of September 2021. This is a -0.4 percent down since the beginning of the trading day. The stock's last reported lowest price was 71.86. Merck has about a 29 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Merck Company are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of March 2021 and ending today, the 27th of September 2021. Please note, there could be an existing legal relationship between Merck Company (MRK) and Merck (SGP). Click here to learn more.
 Market Performance
0 of 100
  Odds Of Distress
Less than 29

Merck Stock Profile

The next fiscal quarter end is expected on the 30th of September 2021. Merck Co., Inc. operates as a healthcare company worldwide. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. Merck operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 73000 people. more on Merck
Merck Company generates negative expected return over the last 90 days
Merck Company has a strong financial position based on the latest SEC filings
Over 75.0% of the company shares are owned by institutional investors
Latest headline from US stocks lower at close of trade Dow Jones Industrial Average down 1.78 percent By -
Merck Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Merck Company SEC Filings
Merck SEC Filings Security & Exchange Commission EDGAR Reports
Legal NameMerck Company
Related EntitySGP (Merck Co)
ChairmanKenneth Frazier  (View All)
Thematic Classifications
Active investing themes Merck currently participates. (showing 3 out of 4 themes ). An investing theme is an unweighted collection of funds, stocks, ETFs or cryptocurrencies
Average Analyst Recommendation
Analysts covering Merck report their recommendations after researching Merck's financial statements, talking to executives and customers, or listening in on Merck's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Merck Company. The Merck consensus assessment is calculated by taking the average forecast from all of the analysts covering Merck.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Merck Company based on its profitability, leverage, liquidity, source of funds, and operating efficiency. it is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Merck Company financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 8 - StrongDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares2.5 B2.5 B
Slightly Down
Slightly volatile
Weighted Average Shares DilutedB2.5 B
Fairly Up
Slightly volatile
Net Cash Flow from Operations9.9 B10.3 B
Sufficiently Down
Very volatile
Total Assets88.9 B91.6 B
Fairly Down
Slightly volatile
Total Liabilities66.2 B66.2 B
Slightly Up
Slightly volatile
Current Assets27.3 B27.8 B
Fairly Down
Slightly volatile
Current Liabilities25.6 B27.3 B
Notably Down
Slightly volatile
Total Debt30.5 B31.8 B
Sufficiently Down
Slightly volatile
Return on Average Assets0.07640.079
Sufficiently Down
Slightly volatile
Gross Margin0.740.677
Significantly Up
Slightly volatile
Asset Turnover0.550.538
Fairly Up
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Merck's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Financial Strength
Merck's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Merck's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Merck's bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Merck's outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest.
AA- ( Average Bond Rating ) Very Strong
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Merck's financial leverage. It provides some insight into what part of Merck's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Merck's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Merck deploys its capital and how much of that capital is borrowed.
Merck cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 31.25 B in debt with debt to equity (D/E) ratio of 1.16, which is OK given its current industry classification. Merck Company has a current ratio of 1.28, demonstrating that it may not be capable to disburse its financial commitments when the payables are due.

Operating Cash Flow

9.87 BillionShare
Merck Company (MRK) is traded on New York Stock Exchange in USA. It is located in 2000 Galloping Hill Road, Kenilworth, NJ 07033, United States and employs 73,000 people. Merck is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with total capitalization of 182.41 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Merck's market, we take the total number of its shares issued and multiply it by Merck's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Merck Company runs under Healthcare sector within Drug Manufacturers—General industry. The entity has 2.53 B outstanding shares of which 22.25 M shares are now shorted by investors with about 1.85 days to cover shorted positions. Merck Company has about 7 B in cash with 10.86 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.76.
Check Merck Probability Of Bankruptcy
Merck Company holds a total of 2.53 Billion outstanding shares. The majority of Merck outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Merck Company to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Merck Company. Please pay attention to any change in the institutional holdings of Merck as this could imply that something significant has changed or about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Ownership Allocation (%)

Check Merck Ownership Details

Merck Stock Price Odds Analysis

What are Merck's target price odds to finish over the current price? Coming from a normal probability distribution, the odds of Merck jumping above the current price in 90 days from now is about 99.0%. The Merck Company probability density function shows the probability of Merck stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Merck Company has a beta of -0.0606. This indicates as returns on benchmark increase, returns on holding Merck are expected to decrease at a much lower rate. During the bear market, however, Merck Company is likely to outperform the market. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Merck Company is significantly underperforming DOW.
 Odds Down 72.04HorizonTargetOdds Up 72.04 
1.18%90 days
Based on a normal probability distribution, the odds of Merck to move above the current price in 90 days from now is about 99.0 (This Merck Company probability density function shows the probability of Merck Stock to fall within a particular range of prices over 90 days) .

Merck Historical Income Statement

Merck Company Income Statement is one of the three primary financial statements used for reporting Merck's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Merck Company revenue and expense. Merck Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Merck Gross Profit is increasing as compared to previous years. The last year's value of Gross Profit was reported at 32.51 Billion. The current Net Income to Non Controlling Interests is estimated to increase to about 15.4 M, while Net Income Common Stock is projected to decrease to under 7.1 B. View More Fundamentals

Merck Stock Against Markets

Picking the right benchmark for Merck stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Merck stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Merck is critical whether you are bullish or bearish towards Merck Company at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Merck without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run My Watchlist Analysis Now


My Watchlist Analysis

Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
All  Next Launch Module

Merck Corporate Directors

Merck corporate directors refer to members of a Merck board of directors. The board of directors generally takes responsibility for the Merck's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Merck's board members must vote for the resolution. The Merck board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Thomas Glocer - Independent DirectorProfile
Craig Thompson - Independent DirectorProfile
Rochelle Lazarus - Independent DirectorProfile
Christine Seidman - Independent DirectorProfile
Additionally, see Stocks Correlation. Note that the Merck Company information on this page should be used as a complementary analysis to other Merck's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for Merck Stock analysis

When running Merck Company price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck Company underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine Merck value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.